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Free fatty acids (FFA) are essential components of the cell, where they play a key role
in lipid and carbohydrate metabolism, and most particularly in cell membranes, where
they are central actors in shaping the physicochemical properties of the lipid bilayer and
the cellular adaptation to the environment. FFA are continuously being produced and
degraded, and a feedback regulatory function has been attributed to their turnover. The
massive increase observed under some pathological conditions, especially in brain, has
been interpreted as a protective mechanism possibly operative on ion channels, which
in some cases is of stimulatory nature and in other cases inhibitory. Here we discuss the
correlation between the structure of FFA and their ability to modulate protein function,
evaluating the influence of saturation/unsaturation, number of double bonds, and cis
vs. trans isomerism. We further focus on the mechanisms of FFA modulation operating
on voltage-gated and ligand-gated ion channel function, contrasting the still conflicting
evidence on direct vs. indirect mechanisms of action.
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Free fatty acids (FFA) are customarily studied in relation to the physical adaptation of cells to
their environment, the normal metabolism of lipids and carbohydrates (lipogenesis, lipolysis,
esterification, oxidation, glycolysis, fatty acid uptake) and disease conditions, such as obesity,
atherogenic dyslipidemias, type 2 diabetes, or insulin resistance (Boden, 2008). This broad palette
is largely associated with the physiology and physiopathology of FFA resulting from the lipolytic
breakdown of stored tissular triglycerides. Other diseases involving pathological affectation of
fatty acids, albeit rare, include X-linked adrenoleukodystrophy, a progressive neurodegenerative
disorder caused by the loss-of-functionmutation in the ATP-binding cassette transporter subfamily
D member 1 gene. The transporter mediates the transport of saturated very long-chain fatty acids
(VLCFA), and the disease displays an abnormal accumulation of VLCFA (Mosser et al., 1993).
In addition to these systemic and more general effects of FFA, the activity of many membrane
proteins is modulated by the lipid composition of the membranes in which they are embedded and
the physicochemical properties of the FFA produced locally are increasingly gaining attention in
this regulatory role. FFA are normal constituents of biological membranes that are continuously
being produced and catabolized in living cells. No consensus view has emerged to date to account
for the mechanisms by which this type of lipids modulate membrane proteins (Ordway et al.,
1991; Petrou et al., 1995); it is highly likely that they will turn out to be multifactorial in nature.
Under certain stress conditions and most particularly in brain, the amount of endogenous FFA can
Abbreviations: FFA, free fatty acids; nAChR, nicotinic acetylcholine receptor; PUFA, polyunsaturated fatty acids; TM,
transmembrane; VLCFA, very long-chain fatty acids.
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increase dramatically, a phenomenon that has been interpreted
as fulfilling a neuroprotective function (see Lauritzen et al.,
2000; Blondeau et al., 2002; Buckler and Honore, 2005). Events
like ischemia, hypoxia and kainate-induced epilepsy cause
a decrease in the intracellular pH, augmented intracellular
FFA concentration and an increase in the cytoplasmic Ca2+
concentration, leading to the activation of phospholipases.
Lauritzen et al. (2000) showed that the PUFA linolenic acid
(n-3 PUFA) prevents neuronal death in an animal model of
transient global ischemia even when administered as long as 30
min after the insult. Linolenic acid also protected animals treated
with kainate against seizures and hippocampal lesions. The
augmentation of both the pH and cytosolic FFA concentrations
causes hyperpolarization of the cell membrane and reduces the
Ca2+ influx, thus deterring excitatory glutamatergic transmission
and preventing neuronal death, pointing to the possible role
of FFA as neuroprotective agents and anti-epileptic compounds
(Lauritzen et al., 2000). In addition, dysfunction in fatty
acid metabolism is implicated in disease conditions, such as
cardiovascular disease, metabolic syndrome, type 2 diabetes,
obesity, hypertension and proimflammatory conditions, as well
as in several neurological diseases related to the alteration
of insulin equilibrium in brain, as observed in Parkinson’s
disease, Alzheimer’s disease and some forms of the schizophrenic
spectrum disorders (Virmani et al., 2015).
It is well documented that FFA can directly or indirectly
affect the activity of a variety of ion channels. The former
involves the interaction between FFA and the ion channel
protein or an associated site within the membrane without
intervening factors or intermediaries; indirect effects involve the
prior transformation of FFA to biologically active metabolites
(Ordway et al., 1991), usually through signaling cascades. FFA
effects on ion channels depend on their chemical structure: some
ion channels are affected by both saturated and unsaturated
fatty acids whereas others are only affected by unsaturated
fatty acids (Ordway et al., 1991; Sumida et al., 1993; Meves,
1994). Similarly, cis and trans FFA isomers have been postulated
to exert effects on some ion channels whereas only the cis
configuration has been identified in other cases (Ordway et al.,
1991; Sumida et al., 1993; Meves, 1994). An example of
this occurs in the hypertriglyceridemia associated with acute
pancreatitis. Hydrolysis of triglycerides by pancreatic lipase in
acinar cells releases large quantities of FFA, which trigger an
increase in cytosolic Ca2+ concentration, an effect that depends
on the unsaturated/saturated FFA ratio. High concentrations of
unsaturated fatty acids lead to an elevation of cytosolic Ca2+
and induce the expression of distinct isoforms of the enzyme
phosphokinase C (PKC), the activity of which directly depends
on the degree of FFA unsaturation (Chang et al., 2015).
Early fluorescence measurements undertaken by Karnovsky
(1979) to study possible membrane alterations induced by FFA
led to the classification of FFA into two groups: group A,
containing cis-unsaturated FFA with a kink in the molecule
(such as oleic and palmitoleic acids), and group B, comprising
saturated and trans-unsaturated fatty acids with a linear structure
(such as stearic and elaidic acids). This structural difference has
important biophysical implications. Group A fatty acids disorder
the membrane’s interior and order the more shallow head group
region, whereas members of group B do not alter the bilayer
core but order the head group region. Such structure-dependent
perturbations can lead to conformational changes in membrane-
embedded proteins, a fact reflected in various communications
reporting differences in biological activity for group A and group
B FFA (Casabiell et al., 1991; Pérez et al., 1997, 2003).
Despite the plethora of studies concerning the relationship
between FFA and proteins—in particular ionic channels and
receptors- it has not been possible to find a common mechanism
of action: whereas in some cases FFA stimulate some functional
property of the protein in question, in other cases they act
as inhibitors. Furthermore, in some cases the structure of the
FFA is determinant (saturated vs. unsaturated; one or two vs.
more double bonds; cis double bonds vs. trans double bonds)
whereas in other cases the detailed chemical structure does
not appear to play a key role; in some cases the FFA acts
directly on the target protein whereas in others the FFA does
so by activating an intracellular cascade that eventually results
in protein modulation. In the following sections, examples of
FFA modulation of distinct ion channels will be discussed
with special emphasis on the voltage-gated ion channels and
the nicotinic acetylcholine receptor (nAChR), paradigm of the
rapid ligand-gated ion channels. From the point of view of the
messenger, in this review we restrict ourselves to the analysis
of the modulatory effects caused exclusively by FFA, without
dwelling on the changes in the membrane microenvironment
produced by the retailoring of the fatty acyl chain composition of
either phospholipid or cholesterol ester molecular species. From
the point of view of the target molecule, we also circumscribe
ourselves to the ion channels, leaving aside e.g., the interesting
field of G-protein-coupled receptors (GPCRs) acting as sensors
of metabolic state, and activated by short-chain fatty acids, i.e.,
the so-called FFA receptors (Hudson et al., 2013).
FFA EFFECTS ON VOLTAGE-GATED ION
CHANNELS
Potassium (K+) Channels
K+ channels comprise a large superfamily of integral membrane
proteins displaying diverse functions in essentially all organs of
vertebrate and invertebrate organisms. Structurally, they possess
several transmembrane (TM) helices spanning the lipid bilayer.
Based on the combination of their structural and functional
characteristics, the K+ channel superfamily can be divided
into three main families: voltage-gated (Kv, 6 TMs), inwardly
rectifying (Kir, 2 TMs), and tandem pore domain (K2P, 4 TMs)
channels (Kuang et al., 2015). The modulation of these channels
by FFA has been documented in numerous instances.
Kv channels are the third-largest class of signal transduction
proteins, second only to G protein-coupled receptors (GPCRs)
and protein kinases (Yu and Catterall, 2004). The pioneer work
of Villarroel and Schwarz (1996) studied the effect of arachidonic
acid (AA) over 12 different K+ channels expressed in Xenopus
laevis oocytes. Different effects (inhibition or enhancement of
the channel current) were observed for each channel; the greatest
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effect was observed in the rat K4.2 channel. The current reduction
in the presence of AA was near 68%, with an almost total
current recovery upon AA removal by washout or bovine serum
albumin addition. A similar effect was observed in the presence
of 5,8,11,14-eicosatetraynoic acid (ETYA), a nonhydrolizable AA
analog. The authors discarded an effect mediated by (1) the
metabolic processing of AA by cyclooxygenase, lipooxygenase or
epoxygenase pathways, (2) an increment in intracellular Ca2+,
or (3) activation of a PKC. By testing different FFA, they also
discarded the possibility that the effect of AA on the Kv4.2
channel was mediated by an indirect mechanism related to
alteration of the membrane fluidity. The authors postulated a
direct mechanism mediated by the specific interaction of AA
with the channel; although they could not find the binding
site for AA, they suggested that the S4–S5 loop is indirectly
involved. In the same work (Villarroel and Schwarz, 1996), the
authors described a potentiation effect of AA on the Shaker Kv
channel, the prototypic member of the family, with perturbations
of the activation and inactivation kinetics, an effect that was
not reproduced with ETYA. Later works continue the study
of this effect. Modulation by FFA of the Shaker Kv channel
shifts the voltage dependence of activation via an electrostatic
mechanism that ends in channel activation (Börjesson et al.,
2008, 2010; Xu et al., 2008). The observed effect was similar
for six different polyunsaturated fatty acids (PUFA), whereas
monounsaturated and saturated fatty acids produced no effect
(Börjesson et al., 2008). The charge of the PUFA head group
determines the direction of the effect, which has been referred
to as the “lipoelectric mechanism” (Börjesson et al., 2008, 2010).
FFA can also induce channel opening by affecting one or
several of the steps/molecular rearrangements leading to channel
opening. Studying point-mutated Shaker channels covering the
lipophilic surfaces of the extracellular helices of S3, S4, S5,
and S6 segments, Börjesson and Elinder (2011) concluded that
residues in the voltage sensor domain are important for PUFA
acting on the channel’s voltage dependence, with high-impact
residues clustered in a small region of the lipid-facing S3–S4
bend, where these authors tentatively assign the location of
the PUFA site of action. Börjesson and Elinder (2011) further
demonstrated that PUFA cause very different effects on different
ion channels depending on the presence of charges at specific
positions. A recent in silico study employing atomistic molecular
dynamics simulations identified a similar potential PUFA site
in the open channel state of Shaker KV, located at the lipid-
facing side of a pocket connecting the extracellular linker between
S3 and S4 helices (Yazdi et al., 2016). This study also provided
an explanation for the activation caused by FFA: the selective
stabilization of the open state of the Kv channel as PUFA
established fewer interactions with the protein in the closed state.
Interestingly, Yazdi et al. (2016) point out that PUFA induce
channel opening by modulating voltage-sensitivity, thus opening
a potential therapeutic avenue for the use of ketogenic diets in
refractory epilepsy.
Background K+ channels (4 TMs and 2 pore domain, 2P)
play a key role in setting the neuronal membrane potential, in
tuning the duration of the action potential and in modulating
the membrane input resistance. Kim (2003) reviewed the
main characteristics of the modulation of two-pore domain
K+ channels by FFA (TREK-1, TREK-2, and TRAAK). These
channels, activated by GPCRs, stretch, pH, and PUFA, are
broadly expressed in the nervous system where they control
neuronal excitability (Lee et al., 2011; Liu et al., 2014; Blin et al.,
2016). The effect of PUFA on TREK channels has profound
physiological implications, since TREK-1 was shown to mediate
the neuroprotection induced by PUFA (Lauritzen et al., 2000;
Heurteaux et al., 2004; Noël et al., 2011; Liu et al., 2014). There
are certain structural features that FFA must necessarily satisfy to
activate these K+ channels: the length of the carbonyl group, the
unsaturation (saturated FFA are not effective) and the presence
of the negatively charged carboxyl group (Patel et al., 2001; Kim,
2003; Noël et al., 2011). It has been demonstrated that the effect
of PUFA on fatty acid-sensitive two-pore domain K+ channels
does not require metabolic conversion of fatty acids into other
bioactive molecules nor cytosolic messengers, enzymes or Ca++
(Horimoto et al., 1997; Maingret et al., 1999; Casavant et al., 2000;
Lee et al., 2011). Thus, the effect of FFA could result from direct
interaction with the channel protein, via partitioning into the
lipid bilayer (e.g., causing changes in membrane fluidity), and/or
involving membrane-delimited signal transduction mechanisms
(Casavant et al., 2000). Compounds that mimic the effect of AA
on membrane properties did not reproduce the effect of FFA
on K+ channels (Patel et al., 2001). TREK and TRAAK are,
however, mechano-gated channels that preferentially open by
negative mechanical pressure (i.e., convex membrane curvature);
it is thus possible that FFA are involved or even inducemembrane
alterations that lead to changes in membrane curvature (Patel
et al., 2001). It has been reported that the cytoplasmic C-
terminal region of near 30 amino acids located close to the 4th
TM segment of the TREK-1 or TREK-2 K+ channels confers
sensitivity to unsaturated FFA (Patel et al., 1998; Kim, 2003;
Lee et al., 2011). Furthermore, using deletion analysis it has
been reported that not only the C-terminal group but also the
extracellular loop between the 1st TM domain and the 1st pore
domain may be important for this effect (Patel et al., 2001).
The large-conductance Ca++-activated K+ channels (Slo1 BK
channels), a very diverse group of channels resulting from
alternative splicing in the CNS, are involved in the regulation of
multiple physiological processes (Brenner et al., 2000). Similarly,
a large number of cellular signaling molecules, including FFA,
are known to modulate the function of Slo1 BK channels.
For instance, BK channels are activated by FFA in GH3 cells
(Denson et al., 2000), whereas a clonal line derived from GH3
(GH4C1) does not respond to AA, suggesting an alternative
BK splice variant in these cells (Duerson et al., 1996). In GH3,
BK channel activation by FFA requires a FA with at least
one double bond, and a significant correlation was described
between the degree of cis-unsaturation and the extent of channel
activation (Denson et al., 2000). No significant correlation
between changes in membrane fluidity and degree of activation
was observed, and no effect of FFA metabolites was detected,
leading to the conclusion that cis-unsaturated FFA interact
directly with the channel protein proper. It was suggested that
binding of the FFA to the Ca2+ binding site (a domain near
the inner surface of the membrane in the cytosolic tail of the
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channel) could be responsible for changes of the channel protein
conformation and hence changes in Ca2+ affinity, resulting
in a conformation with a lower energy state (Denson et al.,
2000). Further structural features of FFA required to increase BK
channel activity have been defined: FFA must have a negatively
charged head group and a sufficiently long (C > 8) carbon
chain (Clarke et al., 2002). These authors showed that channel
modulation is unlikely to be due to an alteration of themembrane
electric field or the attraction of local counterions to the channel,
concluding that FFA modulation of BK(Ca) channels could
occur by direct interaction with either the channel protein
or with some other channel-associated component. Sun et al.
(2007) postulated a novel mechanism of β-subunit-dependent
modulation of BK channels by AA. Further studies also suggested
that docosahexanoic acid (DHA) directly activates the Slo1
channel complex with the auxiliary subunit β1 by destabilizing
the closed conformation of the ion conduction gate (Hoshi et al.,
2013a). Electrophysiological measurements showed that a single
residue near the cytoplasmic end of S6 plays a critical role in
the DHA activation of human Slo1 as no effect was observed on
Drosophila melanogaster Slo1 channels, which normally do not
contain DHA in the body (Hoshi et al., 2013b). Mutation of Y318,
located probably at the cytoplasmic end of S6 in hSlo1 to Y318S,
as found in dSlo1, cancels the effect of DHA on hSlo1 (Hoshi
et al., 2013b).
One of the initial events in β-cells glucose stimulus-insulin
secretion coupling is the closure of the ATP-sensitive K+ channel.
It has been demonstrated that an increment in the concentration
of FFA results in decreased insulin secretion (Corkey et al., 1989).
The effect of FFA was shown to be dual: the initial products
of phospholipase A2 digestion, or exogenous FFA, resulted in
the reduction of ATP-sensitive K+ channel activity, whereas i)
a long-term activation of these channels by AA, and ii) the
reversal of this effect by AA metabolites via the cyclooxygenase
pathway are also observed, possibly responding to a counter-
regulatory mechanism (Eddlestone, 1995). Overnight incubation
of clonal β-cells with palmitic acid induced a 50% decrease in
the ability of glucose to stimulate insulin secretion and increased
the pool of long-chain CoA (LC-CoA, the metabolically active
form of FFA) (Larsson et al., 1996). Oleoyl-CoA increased the
mean current 5-fold. Furthermore, the ability of LC-CoA to
increase K+ conductance appears to be specific for the KATP
channel (and not for the big conductance K+ channel, KBK,
which is voltage and Ca2+-dependent, nor for 8-pS K+ channel).
The stimulatory effect of the LC-CoA was dependent on both
the acyl group (saturated or unsaturated chains with 14 to
18 carbons) and the CoA component. The accumulation of
LC-CoA, possibly as a consequence of high glucose exposure
(which inhibits fatty acid oxidation and elevates cytosolic LC-
CoA levels), could be causally related to a loss of responsiveness
to glucose. In tissue culture or non-insulin-dependent diabetes
mellitus, long-term exposure to FFA impairs glucose-induced
insulin by preventing the closure or promoting the opening of
KATP channels (Larsson et al., 1996). LC-CoA esters with a chain
length exceeding 12 carbons were also observed to be potent
activators of the KATP channel in human pancreatic beta cells
(Bränström et al., 2004). Previously it was demonstrated that
fatty acid activation of ATP-sensitive K+ channels wasmost likely
due to the participation of AA (and other cis-unsaturated fatty
acid)-activated protein kinase C (PKC) isoenzymes and not by
metabolites of AA via the cyclooxygenase or the lipoxygenase
pathways (Müller et al., 1992). Similarly, a direct connection
between AA and PKC activation was experimentally tested,
explaining the mitogenic potential of AA (4-fold increase in
DNA synthesis) in rat brown preadipocytes (Garcia et al., 2012).
AA was in fact shown to activate PKC in various tissues,
albeit by different mechanisms of action (Sekiguchi et al., 1987;
Shinomura et al., 1991; Chen and Murakami, 1992; Blobe et al.,
1995; Nishizuka, 1995; Nowicki et al., 1997; Leu et al., 2010).
AA inhibition of Na+-K+-ATPase in sheep pulmonary artery
was postulated to be mediated mainly by 20-HETE, the major
metabolite of cytochrome P-450-arachidonic acid ω-hydroxylase
pathway, through the activation of PKC (Singh et al., 2012). A
similar mechanism was postulated in rat proximal convoluted
tubules (Li et al., 2000). Nowicki et al. (1997) postulated that this
inhibition wasmediated by PKC-phosphorylation of Ser23 on the
Na+, K+-ATPase α subunit. Another study suggested that 20-
HETE can lead to PKC-dependent phosphorylation of Ser23 in
Na+-K+-ATPase and of Ser896 in NMDA receptor NR1subunits
at the putamen of piglets (Yang et al., 2012). A further study
demonstrated that AA improved prostate cancer cell survival
through 5-lipoxygenase (5-LOX) metabolites, a process which
involved downstream PKCε activity (Sarveswaran et al., 2011).
These authors further showed that treatment of prostate cancer
cells with MK591, a 5-LOX inhibitor, or 5-LOX shRNA not
only decreased PKCε expression but also diminished membrane
localization of PKCε, inducing apoptosis. PKCε may thus be a
mediator of survival signals downstream of 5-LOX metabolites
(Sarveswaran et al., 2011).
Fatty acids act as substrates for acyl-coenzyme A (acyl-
CoA) molecules by several synthases. These activated fatty
acids can be short-chain (acetyl-CoA), medium-chain (e.g.,
octanoyl-CoA) or long-chain acyl-CoAs, such as palmitoyl-
CoA. The effect of FFA and acyl-CoA esters on a highly active
plantmitochondrial ATP-sensitive K+ channel (PmitoKATP) was
studied in mitochondria isolated from durum wheat (Triticum
durum Desf.) (Laus et al., 2011). Acyl-CoAs, linoleate and
other FFA (laurate, palmitate, stearate, palmitoleate, oleate,
arachidonate, and the non-physiological 1-undecanesulphonate
and 5-phenylvalerate) directly activate PmitoKATP, but not
through the Plant Uncoupling Protein (PUCP). The same
activation effect was found to be widespread in mitochondria
from different plant species and organs. Since PmitoKATP may
act against environmental/oxidative stress (Atkin and Macherel,
2009), FFA activation in plants has been proposed to represent a
physiological anti-stress mechanism: under hyperosmotic (NaCl
or mannitol) stress conditions, FFA increase and may activate
PmitoKATP strongly (Laus et al., 2011).
In rat atrial myocytes, perfusion of the cytoplasmic face of
the membrane with unsaturated FFA (10–50 µM) such as AA,
linoleic, and eicosatrienoic acids was reported to inhibit the ATP-
sensitive K+ channel almost completely; lysophospholipids also
markedly inhibited channel openings. In contrast, AA activated
the ATP-insensitive K+ channel with an outwardly rectifying
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property. Since the FFA levels rise after long periods of ischemia,
the authors speculated that the ATP-insensitive K+ channels
contribute to a late phase of extracellular K+ accumulation (Kim
and Duff, 1990).
Ca++-dependent basolateral membrane K+ channel (KCa)
activation in intestinal cells inducesmembrane hyperpolarization
and a Cl− secretory current. It was demonstrated that AA is a
second messenger in this pathway: AA levels increase via Ca2+-
dependent agonists through different pathways (PLA2, DAG, or
DAG lipase) and induce a temporal modulation of Cl− secretion.
The inhibition of KCa can occur both through the extracellular
or intracellular side of the channel and does not depend on the
generation of either cyclooxygenase or lipooxygenase metabolites
(Devor and Frizzell, 1998). This KCa inhibition was not specific
for AA, as other FFA showed similar effects albeit to a lesser
extent. A FFA effect caused by membrane fluidity changes was
discarded as a plausible hypothesis, because different FFA act in
a similar way on KCa but induce deviations from the optimal
membrane fluidity in either direction (Devor and Frizzell, 1998).
Hamilton et al. (2003) concluded that AA exerts a direct effect on
KCa channel (identified as hIK1/hSK4) and described a second-
messenger binding site for AA and other FFA. The AA sensitivity
of hIK1 lies within the S5 pore and the S6 region, two amino acids
(Thr250 and Val275) being crucial for this modulation. The side
chains of both amino acids extend into the hIK1pore, suggesting
that AA causes a direct pore block.
A medically important area of FFA modulation of ion
channels is without doubt the mechanism underlying the anti-
or pro-arrhythmic effects exerted on cardiac ion channels.
PUFA were shown to reduce membrane electrical excitability of
neonatal cardiac myocytes and provide an electrophysiological
basis for the antiarrhythmic effects of these fatty acids (Kang et al.,
1995). Research in this field has developed rapidly and insights
into the action of FFA on cardiac myocytes have exploded. An
example is the multiple and complex series of effects observed
after n-3 supplementation, summarized by Moreno et al. (2012):
“n-3 PUFA inhibit the fast sodium current (INa), ultrafast
activating delayed outward potassium current (IKur), transient
outward potassium current (Ito), rapidly activating delayed
rectifying outward potassium current (IKr), L-type calcium
inward current (ICa), and NaC-Ca2C exchange current (INCX),
and enhanced slowly activating delayed rectifying outward
potassium current (IKs) and inward rectifying potassium current
(IK1).” It is still not clear, however, which is the mechanism
operative in n-3 FFA modulation of ion channels: is it a direct
or an indirect effect? The prevalent opinion is to consider a direct
interaction of FFA with the ion channel protein proper (Moreno
et al., 2012 and references therein). Guizy et al. (2005) reported
a blocking effect of both AA and DHA on human ether-a-go-go-
related gene (HERG) channels, whose activation determines the
duration of the action potential. This effect, which was found to
depend on time, voltage and channel conformational state, was
compatible with an open-channel blockmechanism. The fact that
ETYA caused a similar blockage effect suggests that these PUFA
act through a direct mechanism and not through AAmetabolism.
Clearly, this mechanism requires the channel to be in an open
state, but changes in the channel gating parameters suggest that
these FFA also interact with the closed state. The inhibition action
of these FFA on HERG channels can help to further explain
the reported antiarrhythmic effects of AA and/or DHA (Guizy
et al., 2005). Open-channel blockage by polyunsaturated FFA,
apparently by binding of the FFA to an external site in the
channel, was also reported for the major voltage-dependent K+
channel (Kv1.5) cloned from cardiac cells (Honoré et al., 1994;
Guizy et al., 2008). In contrast to this effect, Gavrilova-Ruch
et al. (2007) reported that AA activated human ether à go-go
(hEAG) potassium channels expressed in CHO cells, an effect
totally reversed upon washing with BSA. The potentiation effect
was directly dependent on the number of cis-double bonds in
the FFA, and probably involved a direct mechanism of action,
as ETYA also potentiated hEAG currents, presumably acting
through the outer membrane leaflet. The fact that FFA activate
hEAG channels whereas they inactivate HERG channels may
be due to structural differences in the pore mouth which, in
the case of hEAG channels, would prevent the access of AA to
the permeation pathway. These channels are normally expressed
in neuronal tissue but also in various tumoral tissues, pointing
to a possible oncogenic role; the activating effect of AA on
EAG channels has therefore been related to an enhanced tumor
proliferative rate (Gavrilova-Ruch et al., 2007).
Anion Channels
Anion channels, ClC-2 Cl− channels in particular, are widely
distributed in epithelial and non-epithelial tissues. One of the
potentially lethal, inherited diseases affecting Cl− channels is
cystic fibrosis. The disease is caused by mutations in the
gene encoding a cAMP-regulated, phosphorylation-gated Cl−
channel, the cystic fibrosis transmembrane conductance regulator
(CFTR). CFTR-mediated Cl− and bicarbonate transport drives
fluid secretion across epithelial cells. In the gastrointestinal
tract, the pathological alteration or loss of CFTR function
severely hampers the production of exocrine pancreatic and
intestinal secretions, leading to incomplete food digestion and
malabsorption. In CF newborns, the defective fluid secretionmay
lead to a life-threatening obstruction of the distal small intestine,
the so-called meconium ileus syndrome. In the pulmonary
tract, the CFTR plays a major role in maintaining the airway
surface protected by a fluid biofilm. It is therefore not surprising
that the respiratory tract is often the target of secondary
infections and pneumonia by the combination of CFTR and
defective mucosal immunity, Pseudomona aeruginosa being the
main pathogen involved. The CFTR is inhibited by several
fatty acids in the following order: linoleic ≥ arachidonic ≥
oleic > elaidic ≥ palmitic ≥ myristic (Linsdell, 2000). The
mechanism of AA inhibition has been suggested to result
from the electrostatic interaction of the FFA with positively
charged amino acids located at the cytoplasmic vestibule of
the CFTR channel pore (Zhou and Linsdell, 2007), pointing
to a more general inhibitory mechanism of apical membrane
Cl− channels by different FFA, which would act from the
cytosolic surface thus rejecting the idea that inhibition results
from changes in membrane fluidity (Anderson and Welsh,
1990).
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Mutations in the CFTR Cl− channel are associated with severe
lung disease in about 5% of cystic fibrosis patients, a condition
that may lead to death. Consequently, a possible therapeutic
approach for cystic fibrosis is the potentiation of alternative
pathways for Cl− transport in the lung, including the targeting
of ClC-2 Cl− channels in the epithelium of the respiratory
tract. These channels were found to be activated by oleic, elaidic
and arachidonic acids and by cAMP-dependent PKA, but AA
was found to increase the Cl− currents in a PKC-and PKA-
independent manner (Tewari et al., 2000). The increment of
Cl− currents was FFA dose-dependent, and only observed with
unsaturated FFA indistinctly of cis or trans isomerism. The
authors postulated that the effect of FFA may be due to direct
effects on the channels, probably through mechanisms similar
to those underlying the effect of FFA on the TREK-1 channel
described above, and not to products of FFA metabolism (Tewari
et al., 2000).
Sodium (Na+) Channels
Cardiac Na+ channels (the major class of ion channels
that determines cardiac excitability) are also modulated by
FFA, causing a reduction in the electrical excitability and/or
automaticity of cardiac myocytes. Here again, it is postulated
that the inhibition is dependent on FFA structure (Kang et al.,
1995; Xiao et al., 1995), reversible in the presence of BSA,
and not mediated by FFA metabolites (Kang and Leaf, 1996;
Xiao et al., 1997). The mechanisms by which they exert their
action remain uncertain; however, it is postulated that FFA act
as non-competitive inhibitors, through a single class of sites,
by an allosteric inhibitory mechanism (Kang and Leaf, 1996).
These authors postulated a model in which the FFA hydrophobic
portion interacts with the hydrophobic TM domains of the
channel protein at either the lipid-channel interface or at the
space between hydrophobic protein domains; the negatively
charged carboxyl group interacts ionically with the positively
charged amino acid residues of the channel protein near the
surface of the bilayer where the carboxyl group is anchored.
Cardiac Na+ channels consist of two subunits: the α subunit
(the largest one, itself constituting a functional channel) and the
β subunit (smaller; it interacts functionally with the regulatory
segments of the Na+ channel) (An et al., 1998). FFA rapidly and
strongly suppress voltage-gated Na+ currents in cells transfected
with only the α-subunit of the human cardiac Na+ channel and
prolong the duration of its inactive state, probably by binding
to the inactivated form of the channel (in this state the channel
displayed a 43-fold higher affinity for FFA than channels in the
resting state) (Xiao et al., 1998). However, not only PUFA but
all FFA exerted effects, leading these authors to the conclusion
that the characteristic specificity of the effects of PUFA on native
Na+ currents was lost in the exclusive presence of the Na+
channel α subunit. Xiao et al. (1998) also postulated that the
configuration of the α-subunitmay bemore open or uncovered in
the absence of other components of the intact voltage-dependent
human cardiac Na+ channel, thus allowing even those FFA
lacking the two or more double bonds to gain access to the site(s)
at which PUFA affect conductance in the complete channel.
The authors suggested that a short cytoplasmic segment of the
transfected channel, linking the III and IV TM segments, was
the site of action of FFA (Xiao et al., 1998). Co-expression of
the β-subunit with the α-subunit of the human cardiac Na+
channel restores the selective effect of the PUFA, leading to the
conclusion that the β-subunit modifies the FFA blockage of the
Na+ channel (Xiao et al., 2000). A study with the hH1(α) Na+
channel led to the discovery of the importance of Asn 406 in
the inhibition of cardiac voltage-gated Na+ currents by PUFA
(Xiao et al., 2001). Another study using cells transfected with
the skeletal muscle sodium channels (SkM1) isoform showed
that ion channel modulation by FFA depends on the mode
of FFA administration (Wieland et al., 1996). Intracellular AA
exposure increased channel currents whereas the hH1 isoform
did not show significant current increases. Thus, the response
to FFA must include an isoform-specific element. In contrast,
both isoforms were inhibited when unsaturated FFAwere applied
extracellularly. These results point to the existence of two
distinct sites and mechanisms for FFA modulation of sodium
channels: a potential extracellular site for extracellular FFA, and
an intracellular one that appears to be exclusively for SkM1.
The activation effect was observed over 120 min, suggesting
that neo-synthesis and trafficking/insertion of new channels to/in
the cell membrane could occur during this period, alone or in
combination with unmasking of reserve channels already present
in the plasmalemma (Wieland et al., 1996). This dual mechanism
was also observed in the muscle rNa(V)1.4 channel isoform,
which appears to depend on the depolarizing potential: AA, but
not its metabolites, increased the channel current evoked by
a−30 or−40mV depolarization of the membrane potential, but
significantly decreased it by a depolarization over −10mV (Gu
et al., 2009). It was also reported that cis-unsaturated FFA with
a double bond at position 9 have a biphasic effect on connexin
46 hemichannels: current activation at low FFA concentration
and current inhibition at higher concentrations, the effect being
directly proportional to the number of double bonds (Retamar
et al., 2011). The authors ruled out the possibility that the biphasic
effect was mediated by changes in the biophysical properties
of the plasma membrane. They concluded that activation and
inhibition current mechanisms involve different sites of action
(Retamar et al., 2011).
A different dual mechanism of AA action has been postulated
for the modulation of δ-opioid receptor (DOR) function
(Sullivan et al., 2015). This modulation involves regulation
by cyclooxygenase (COX) and lipoxygenase (LOX) dependent
metabolites and activation of PKC. A COX-dependent metabolite
of AA induces a responsive state of DOR that is capable of
mediating antinociception and inhibition of adenylyl cyclase
activity in response to opioid agonists, whereas a novel LOX-
dependent metabolite of AA produces a loss of responsiveness
of the DOR system. Sullivan et al. (2015) further demonstrated
that exogenously added and endogenously produced AAs follow
different metabolic processes, pointing to the existence of
subcellular compartmentation of the enzymes involved. This dual
regulation of DOR function may explain the observed variations
in the efficacy of opioids in the treatment of pain. Another dual
mechanism of FFA is described below for nicotinic acetylcholine
receptors.
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FFA EFFECTS ON IONOTROPIC
NEUROTRANSMITTER LIGAND-GATED
ION CHANNELS
The regulation of rapid ligand-gated ion channels by fatty acids
is illustrated using two paradigmatic cases, the γ-amino butyric
acid receptor and the nicotinic acetylcholine receptor.
γ-Amino Butyric Acid Receptor (GABA-R)
Exogenously added unsaturated FFA, or endogenously produced
by the cell, modulate the GABA-R by drastically altering the
binding characteristics of various GABA-R ligands, underlying
the importance of the lipid environment for this process
(Schwartz et al., 1988; Koenig and Martin, 1992; Samochocki
and Strosznajder, 1993; Witt and Nielsen, 1994; Witt et al.,
1996). FFA acting on the GABA-R must have at least one C-C
double bond and a carbon length of 16–22 C (Witt and Nielsen,
1994). The effect of FFA on GABA/benzodiazepine receptor Cl−
channel complex from mammalian, avian, amphibian, and fish
species was studied in vitro (Witt and Nielsen, 1994). Different
effects of unsaturated FFA were observed on [3H]diazepam
and [3H]muscimol binding: FFA enhanced ligand binding in
the case of mammalian and amphibian receptors; of 17 fish
species studied, 11 species presented weak stimulation of ligand
binding, 4 species did not show augmented stimulation and
2 species exhibited inhibition; in the 10 bird species studied,
only weak enhancement of [3H]muscimol binding was found,
whereas [3H]diazepam binding was similar to mammal species
(Witt and Nielsen, 1994). These results point to phylogenetic
differences in the receptor that might account for the differences
in FFA modulation. Again it is possible to consider a direct
or an indirect FFA mechanism for GABA-R modulation. The
argument for indirect effects rests on the fact that ontogenetic
differences also involve changes in membrane composition, as
fish membranes are composed mainly of phospholipids with
unsaturated fatty acids and, hence, a further fluidizing effect
by exogenously added unsaturated FFA is unlikely (Witt and
Nielsen, 1994). However, an increase in the temperature of the
binding assay, which induced an increment inmembrane fluidity,
did not alter the unsaturated FFA effect on ligand binding to
GABA-R. Evidence pointing to a direct mechanism included the
study of FFA effects on distinct recombinant human GABAA-R
complexes formed by different subunit compositions (α, β, and γ
subunits) where a modulation of the ligand binding by FFA was
dependent on the subunit combination. These results suggest the
existence of specific amino acid sequences in the α subunits that
confer FFA sensitivity to the GABAA-R (Witt et al., 1996, 1999).
Additional data suggest that FFA bind to specific sites, unleashing
apparently independent responses: the rapid potentiation of the
GABA currents and the increased desensitization of the GABA-
R complex, which requires the presence of the γ2 subunit
(Nabekura et al., 1998). Thus, the combination of different
factors, such as the type and concentration of FFA plus the
various combinations of GABA-R subunits in the same neuron
result in a broad spectrum of potential modulatory mechanisms
which might affect GABA responses in the CNS. The mechanism
of FFA modulation on GABAA receptors –activation of second
messenger systems- appears to be shared by another inhibitory




“A protein isolated from Naja naja siamensis venom on the basis
of its phospholipase A activity inhibits acetylcholine receptor
function in post-synaptic membrane vesicles from Torpedo
californica” (Andreasen and McNamee, 1977). This was the first
evidence linking FFA with nAChR function. Shortly after, it was
demonstrated that incorporation of unsaturated fatty acids or
lyso-phosphatidylcholine intoTorpedomembranes also inhibited
nAChR function whereas lyso-phosphatidylethanolamine and
most saturated FFA caused no effect (Andreasen et al., 1979).
This inhibitory effect could be reversed and/or prevented by
treatment with bovine serum albumin. Spin-labeled fatty acids
also inhibited Torpedo nAChR, the magnitude of this effect being
largely dependent on the position of the nitroxide group along
the hydrocarbon chain (Andreasen and McNamee, 1980). The
FFA inhibitory effect on nAChR function was attributed to the
perturbation of protein-lipid interactions, and the magnitude of
the effect was found to depend on FFA structure (Andreasen
and McNamee, 1980). Alterations in nAChR function by FFA,
particularly linolenic acid, or by phospholipase A2 hydrolysis
products were directly correlated with perturbations of nAChR
structure (Villar et al., 1988).
We analyzed the effect of four long-chain free fatty acids
(AA, 20:4; DHA, 22:6; palmitic acid, 16:0; and nonadecanoic
acid, 19:0) on the function of the acetylcholine receptor (nAChR)
at the single-channel level (Bouzat and Barrantes, 1993a). The
effect had a rapid onset and only very brief opening events were
apparent after FFA application. The modification appeared not
to be critically dependent on the degree of FFA saturation. In
intact cells, fatty acids could reach and affect nAChR channels
in the plasmalemma under the patch pipette when added from
outside the patch-clamped area, suggesting i) that fatty acids
diffused laterally and ii) the possibility that the AChR-lipid
interface was the site of action of FFA (Bouzat and Barrantes,
1993a).
Free fatty acids (FFA) display the highest affinity for the
native membrane-bound nAChR among all lipids studied to date
(Marsh and Barrantes, 1978; Ellena et al., 1983; Dreger et al.,
1997; Mantipragada et al., 2003). We subsequently disclosed the
occurrence of independent sites for phospholipids and sterols
in native nAChR membranes (Antollini and Barrantes, 1998),
and found that these discrete sites were both accessible to FFA.
From fluorescence quenching studies using nitroxide spin labels
we also tentatively concluded that the sites were located at a
shallow depth close to the phospholipid polar head region in
native nAChR membranes (Barrantes et al., 2000). However,
despite being located at the same site, each class of FFA differs in
its effect on the physical properties of the membrane depending
on its structure. Using the polarity-sensitive fluorescence probe
Laurdan, it was possible to distinguish between saturated FFA,
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which induced a small increase in membrane order, and cis-
unsaturated fatty acids, which caused a clear decrease of the
lipid order. Double-bond isomerism could also be distinguished:
oleic acid (18:1cis) induced a net disordering effect, whereas
elaidic acid (18:1trans) produced no changes in membrane
order (Antollini and Barrantes, 2002). These data lead us to
suggest that it is the direct action of FFA at the lipid-protein
interface, displacing essential lipids from their sites, rather
than changes in bulk properties, such as membrane fluidity,
that accounts for the inhibitory effect of FFA on nAChR
function.
Two types of lipid sites have been described to be present in
integral membrane proteins in general, and at the lipid-nAChR
interface in particular: annular and non-annular sites. Annular
sites constitute the first shell of lipids surrounding the protein and
interact with the protein in a relatively less specific manner; the
rate of exchange between annular shell lipid and bulk membrane
lipid is relatively fast, in the order of 1–5 × 108 s−1 (Marsh and
Barrantes, 1978; Barrantes, 2004). Non-annular lipid sites involve
spaces between TM helices and between subunits in multisubunit
proteins (Lee, 2004). Non-annular lipids are considered essential
for protein activity, and display higher specificity for the protein.
The rate of exchange of non-annular lipids with bulk lipids
has not yet been experimentally determined, but is presumably
sluggish, and in any case much slower than that of annular
lipids, as a result of the high specificity of the interaction
between non-annular lipids and the protein (Lee, 2004). On
the basis of competition studies, early studies suggested that
non-annular lipids were associated with binding sites to which
cholesterol is bound but phospholipids are not (Jones and
McNamee, 1988). We demonstrated that both endogenous FFA
generated by phospholipase A2 from Torpedo native membranes
and AA exogenously added to these membranes localize at
both annular and non-annular sites at the lipid-protein interface
(Fernández Nievas et al., 2007). Furthermore, we found that
nAChR conformational transitions between the resting (R) state
and the desensitized (D) state may entail a rearrangement of
the nAChR TM region involving the occlusion of non-annular
sites at the lipid-protein interface or simply decreased lipid
efficacy in accessing such sites (Fernández Nievas et al., 2007;
Figure 1).
Taking advantage of the different affinities that the
fluorescence dye crystal violet (CrV) displays for the resting (R)
and desensitized (D) states of the nAChR we observed that the
dissimilar effects that FFA exert on the receptor conformational
states depend on the structural characteristics of the fatty acids
(Fernández Nievas et al., 2008). Whereas cis-FFA increased
membrane polarity, trans-FFA and saturated FFA caused
essentially no changes in this property. Only cis-FFA drove
the nAChR out of the R state in the absence of agonist; we
hypothesized that most likely direct contacts between the FFA
and TM portions of the nAChR are responsible for driving
the receptor out of the R state and, hence, inhibit its function.
cis-FFA caused a second effect on membrane-bound nAChRs:
they prevented the receptors from reaching the D state in the
presence of agonist. This lack of transition to the D state of
the nAChR could be mimicked by raising the temperature,
which disorders the membrane bilayer, or by treatment with
PLA2, which decreases the polarity of the membrane, two
conditions that do not perturb the R state of the nAChR.
The second effect seems not to depend on the presence of
specific molecules at the lipid-nAChR interface but rather to be
unspecific, mainly associated with changes in the physical state
of the bulk membrane. Thus, whereas foreign molecules at the
lipid-protein interface probably modify the “activation gate” of
the nAChR-associated channel, leading to an intermediate D
state, changes in the physical state of the membrane (particularly
changes in membrane order or polarity) are likely to perturb
the “desensitization gate” (Fernández Nievas et al., 2008;
Figure 2). A previous study with single cells obtained from flexor
digitorum brevis muscles of adult male mice also correlated
nAChR functional inhibition with nAChR protein conformation
(Nojima et al., 2000). These authors demonstrated that AA,
and prostaglandin D2 (PGD2) or its metabolites, cooperatively
accelerate desensitization of the nAChR. The explanation
provided invoked the activation of PKC by AA and PGD2
in this mechanism. However, the experiments of Fernández
Nievas et al. (2008), performed in isolated nAChR-rich plasma
membranes in the absence of phosphorylation (absence of ATP
and insufficient Mg2+ concentration; Safran et al., 1990) clearly
demonstrated the inhibition and conformational changes of the
nAChR, suggesting that the inhibition and desensitization of the
nAChR by FFA does not involve PKC activity. Putting all the
information together reinforces the view that there is more than
one mechanism of action involved in the modulation of nAChR
function by FFA.
In order to further dissect the mechanisms of action of
cis-unsaturated FFA on the native membrane-bound Torpedo
nAChR, we resorted to the use of five different monounsaturated
fatty acids with the same number of carbon atoms (cis-6-18:1, cis-
9-18:1, cis-11-18:1, cis-13-18:1, and trans-9-18:1) (Perillo et al.,
2012). Four out of five 18:1 FFA tested (cis-9-18:1, cis-11-18:1,
cis-13-18:1, and trans-9-18:1) were found to localize at both
annular and non-annular sites; only cis-6-18:1 was found in
annular sites. Membrane order was found to undergo a very
slight and saturable decrease in the presence of the trans-
unsaturated FFA, whereas all cis-monounsaturated FFA tested
causedmembrane order perturbations dependent on the position
of the double bond. The largest effect was observed when the
double bond was near the middle of the acyl chain. Patch-clamp
experiments disclosed the inhibition of nAChR currents only
with cis-9-18:1 or cis-6-18:1. All unsaturated FFA prevented the
nAChR from reaching the D state in the presence of agonist
but only cis-9-18:1, cis-11-18:1, and cis-13-18:1 drove the AChR
out of the R state in the absence of agonist. Finally, only cis-
monounsaturated FFA caused a local topological change in the
nAChR γTM4 segment (cis-6-18:1 to a lesser extent) (Table 1).
Taken together, these data led us to conclude that the position of
the torsion angle of unsaturated FFA is a key factor in channel
blockage. If one takes into consideration that (i) the sequence
of structural events coupling ligand binding to channel gating
begins with movements at the ligand-binding loops, is followed
by the displacement of loops located at the interface between
the extracellular ligand binding domain and the TM domain, the
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FIGURE 1 | (A) Schematic diagram of a direct mechanism of action of FFA on nAChR function. The scheme illustrates the nAChR-lipid relationship in a receptor-rich
membrane, outlining the spatial distribution of the transmembrane segments (TM1, TM2, TM3, and TM4) and the surrounding lipid shell. Three lipid topologies are
indicated: non-annular lipids (bordeaux •), annular lipids (green •) and bulk lipids (light blue •). FFA (blue N) can be found in any of these three domains. (B,C)
Experimental studies on annular and non-annular sites using the efficiency (E) of the Förster resonance energy transfer (FRET) process between the intrinsic
fluorescence of T. californica nAChR membranes and the extrinsic fluorescent probe Laurdan; (B) in the presence of increasing concentrations of DOPC (),
cholesterol hemisuccinate (CHS, N), and oleic acid (•), where the symbol (♦) corresponds to the sum of E of DOPC and CHS (from Antollini and Barrantes, 1998) and
(C) in the presence of increasing concentrations of arachidonic acid with the nAChR in the resting (“R”, ♦) or the desensitized (“D”, ) state. The latter was generated
by incubation of the membrane with 1mM carbamoylcholine prior to the fluorescence measurements (From Fernández Nievas et al., 2007).
subsequent tilting/bending of the pore-lining M2 helix, and ends
with movements of M4, M3, and M1 helices in the TM domain
(Mitra et al., 2004; Auerbach, 2005), and (ii) that FFA might
exert their action by an allosteric mechanism at the lipid-nAChR
protein interface, those FFA with the double bond at a shallow
position in the membrane probably share the topological loci of
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FIGURE 2 | Sequential model of the nAChR activation equilibrium. The
model considers that each state of channel activation has a corresponding
desensitized state (Dilger and Liu, 1992): R is the nAChR in the resting state, A
the agonist and RA and RA2 represent the nAChR with one or two agonist
molecules bound, respectively, and RA2* is the biliganded nAChR in a
transient active open configuration; D, AD, A2D, and A2D* are the
corresponding isoforms in the desensitized, non-conductive states,
respectively. This allosteric equilibrium can be affected e.g., by single-point
mutations and exposure to some drugs (From Fernández Nievas et al., 2008).
the conserved core structure for nAChR gating and hence could
perturb this synchronous mechanism (Perillo et al., 2012).
Changes in membrane lipid composition (Criado et al., 1984;
Sunshine and McNamee, 1994; Baenziger et al., 2000; da Costa
et al., 2002) and/or the presence of exogenous hydrophobic
molecules like steroids and fatty acids (Andreasen andMcNamee,
1980; Villar et al., 1988; Bouzat and Barrantes, 1993a,b, 1996;
Lasalde et al., 1995; Nurowska and Ruzzier, 1996; Santiago
et al., 2001; Garbus et al., 2001, 2002) affect AChR function.
Individual amino acid mutations in the lipid-facing outer ring
(M4) of the nAChR TM domain also modulate nAChR function
(Lee et al., 1994; Lasalde et al., 1996; Ortiz-Miranda et al.,
1997; Bouzat et al., 1998; Tamamizu et al., 1999, 2000), a clear
indication that although far away from the agonist sites and
from the ion channel, the M4 TM segment, the only member of
the outermost TM ring (Barrantes, 2003), effectively influences
nAChR function. In this sense, M4 would behave as a sensor
of the lipid-protein environment unleashing a signal to the M2
channel region, probably initiated by the induction of changes
in the topology of the outer ring and ultimately causing a
conformational change of the whole AChR (Xu et al., 2005;
Fernández Nievas et al., 2007, 2008; Perillo et al., 2012; Barrantes,
2015).
Contrary to the rapid inhibitory effect described above, a
potentiation effect of AA on Torpedo nAChR expressed in
Xenopus oocytes, lasting over 30 min after FFA washing, has
been reported (Ikeuchi et al., 1996). This effect resembles the
dual action of FFA on Na+ channels described in previous
sections. Pretreatment with PKC inhibitors did not counteract
the FFA inhibition but abolished the potentiation effect. However,
experiments performed with mutant nAChR lacking PKC
phosphorylation sites showed no current blocking effect of AA
and a current potentiation greater than in the control condition.
Together, these results pointed to two different and independent
mechanisms: a short-term blocking mechanism through direct
action of AA on nAChR PKC phosphorylation sites, rather
than through an effect on the membrane environment; and a
long-term potentiating mechanism caused by PKC activation
not involving nAChR phosphorylation. This second mechanism
must include an unknown pathway related to AA-regulated
PKC. Different results were observed depending on the FFA
structure. Treatment with linoleic (18:2) or linolenic (18:3)
acids caused similar dual effects on Torpedo nAChR; however,
the long-term potentiation was not evident in mutant nAChR,
indicating that these FFA, in contrast to AA, did in fact potentiate
nAChR via its PKC phosphorylation site (Nishizaki et al., 1997a).
On the other hand, current potentiation by treatment with
oleic acid (18:1) was not hindered by PKC inhibitors but fully
inhibited by KN-62, a calmodulin-dependent protein kinase II
(CaMKII) inhibitor, suggesting that oleic acid enhances nAChR
currents by activation of CaMKII, independently of the PKC
pathway (Nishizaki et al., 1997b). This can be accounted for
by the explanation provided by Gérczy et al. (2012), pointing
to the AA selectivity of certain PKC isoforms over several
other signal-transduction mechanisms. Lysophosphatic acid also
enhances Torpedo nAChR currents both in control and in
mutant nAChRs lacking PKC phosphorylation sites; however,
the potentiation was also completely blocked by GF109203X
(Nishizaki and Sumikawa, 1997). These authors suggested
that lysoPA probably potentiates nAChR currents by pertussis
toxin-insensitive G-protein and activation of Ca2+-dependent/-
independent PKCs with subsequent phosphorylation of the
receptors and, additionally, by an unknown factor or process
activated by PKC activation. Saturated FFA with less than 20
C atoms also potentiate nAChR currents with the participation
of PKC, stearic acid (18:0) being the most potent FFA in
this respect (Ohta et al., 2003). A comprehensive study of
the importance of the FFA structure (Yaguchi et al., 2005)
concluded that FFA modulation of nAChR current could not be
simply explained by the number and position of the cis-double
bonds. This study showed that 20:1ω12 (8-eicosenoic acid)
potentiated the currents without depression, whereas 20:1ω15
(5-eicosenoic acid) and 20:1ω9 (11-eicosenoic acid) elicited
only the depression component, suggesting that cis-double bond
at the 8th position plays a role in the potentiation and at
the 5th or 11th position in the depression. This rule agrees
with the fact that 20:3ω9 (5,8,11-eicosatrienoic acid), 20:4ω6
(5,8,11,14-eicosatetraenoic acid), and C20:5ω3 (5,8,11,14,17-
eicosapentaenoic acid) induced a transient inhibition followed
by enhancement of the currents, whereas 20:3ω6 (8,11,14-
eicosatrienoic acid) induced only nAChR depression and not
potentiation (Yaguchi et al., 2005). It should be noted, however,
that 20:2ω6 (11,14-eicosadienoic acid) has no double-bonds at
crucial positions and it has a dual effect on nAChR currents.
The carboxy-terminal group appears to play a critical role in the
potentiation of the nAChR, as this group is necessary for PKC-
ε activation; replacement of COOH in linoleic acid by CONH2
(linoleoylamide) only caused the depression effect (Yaguchi et al.,
2005).
The work of Vijayaraghavan et al. (1995) was the first
demonstration that FFA also modulate neuronal-type nAChRs.
Using chick ciliary ganglion neurons these authors showed that
seconds of incubation with AA sufficed to inhibit neuronal
nAChR with a distinct and largest effect on the α7-type
nAChR. This inhibition was not restricted to AA but also
included other FFA in a structure-dependent manner: saturated
or cis/trans monounsaturated FFA showed little or no effect;
FFA having two or three double bonds exhibited inhibitory
Frontiers in Physiology | www.frontiersin.org 10 November 2016 | Volume 7 | Article 573
Antollini and Barrantes Fatty Acids and Channels
TABLE 1 | Summary of effects produced by different FFAs on the nAChR (Perillo et al., 2012).
Petroselenic acid Oleic acid Vaccenic acid Octadecanoic acid Elaidic acid (18:1 trans-9)
(18:1 cis-6) (18:1 cis-9) (18:1 cis-11) (18:1 cis-13)
Sites at lipid-nAChR interface Aa A + NAb A + NA A + NA A + NA
inhibition of nAChR function + ++ – – –
GP modification ++ +++ ++ + –
Anisotropy modification + +++ ++ ++ –
nAChR TM4 perturbation + ++ ++ ++ –
R-state perturbation – ++ ++ ++ –
D-state perturbation ++ ++ + + +
The CPK structures of the FFAs studied are shown for clarity: the broken line shows the position of the cis double bond and the arrow indicates the position of the trans double bond.
aA, annular sites; bNA, non-annular sites.
effects, and AA displayed maximal effect. The authors concluded
that the inhibition must be caused by a direct action of the
FFA on the nAChR or through the membrane, discarding
the possible action of AA metabolites or the activation of
PKC. Minota and Watanabe (1997) also showed that AA
directly inhibits nAChR in bullfrog sympathetic ganglia, and
that its metabolites do not play a major part in this inhibition.
Two general possibilities were postulated to account for this
mechanism: (i) AA binds to allosteric sites of the nAChR –one
possibility being a site in the channel pore- thus inhibiting
synaptic transmission without affecting the binding of ACh
to the receptor; or (ii) AA perturbs the local environment of
the receptors by partitioning into the membrane and thereby
indirectly inhibiting receptor function. Nishizaki et al. (1998)
indicated that neuronal nAChRs display short-term depression
and/or long-term enhancement of nAChR currents depending
on the biological source of the neuronal nAChR. Treatment
of chick α7 nAChR with AA caused only a depression effect
(in accordance with Vijayaraghavan et al. (1995)) whereas
in the case of rat α7 nAChR the same treatment caused
exclusively a potentiation effect by PKC activation. This strongly
suggests a relation between FFA effect and nAChR structure;
the different response to AA may probably be due to structural
differences between receptors. Further studies with rat α7 and
α2β4 nAChR showed that AA increases glutamate release by
potentiating the activity of presynaptic nAChRs, predominantly
α7 nAChR, under the influence of PKC, an effect not related
to CaMKII activity (Nishizaki et al., 1999). Stearic acid has
also been shown to potentiate α7 nAChR currents, with the
involvement of PKC in this potentiation (Ohta et al., 2003). The
latter work demonstrated that although stearic acid enhances
activity of already active PKC-ε it does not directly activate this
enzyme.
Studies of the FFA modulation of different proteins through
PKC indicate that, in some cases, the mechanism involves not
a direct PKC activation but an increased expression and altered
subcellular distribution of PKC. It is known that translocation
of PKC isoforms is generally regarded to be indicative of their
activation. Li et al. (2010) explained the induced pulmonary
artery (PA) contraction by hypoxia through an important
increment in both the RNA levels and protein expression of
PKC-δ and PKC-ε induced by 15-hydroxyeicosatetraenoic acid
(HETE). In this case, AA is metabolized by 15-lipoxygenase,
which is up-regulated by hypoxia, to 15-HETE which causes
pulmonary artery (PA) constriction by activation of PKC-δ
and PKC-ε. A similar profile was described in HEK293 cells,
where AA displays a biphasic effect on Ca2+ signaling: at low
concentrations, AA suppresses both Ca2+ release and Ca2+
influx responses to agonist; whereas at high concentrations, AA
potentiates Ca2+ release and Ca2+ entry response (Chen et al.,
2012). These authors postulated that AA induces PKCα and
PKCβII redistribution at the plasma membrane, and that at
higher AA concentrations trafficking of PKCβI and PKCβII to
the endoplasmic reticulum also occurred. A totally opposite effect
was described in a study of the immunomodulatory properties
of PUFA in phagocyte function (Gorgani et al., 2011). These
authors demonstrated that AA causes a significant decrease in
CRIg expression at both the mRNA and protein levels, and that
this down-regulation is dependent on PKC activation by AA
excluding the possibility that AA could exert its effect through
its metabolism via cyclooxygenase and/or lipoxygenase.
It is important to highlight that the FFA concentrations used
in all the studies mentioned here were below the high FFA levels
reported in several pathological conditions as a consequence
of PLA2 activation and FFA release from plasma membranes.
Arachidonate levels in the plasma of malaria patients are in the
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order of 100 µM (≈ 33.3 µg·mL−1) (Eissen, 1993) and under
ischemic conditions these levels can rise to 500 µM, 10-fold
higher than the free AA levels found in normal brain (Yasuda
et al., 1985). A 10-fold increment in FFA was also reported in an
experimental model of acute lung injury (Arbibe et al., 1998).
More recent studies used FA derivatives to explore in
more detail the modulatory mechanism exerted by FFA on α7
nAChR. FR236924, a linoleic acid derivative, was synthesized
having cyclopropane rings instead of cis-double bonds. The
FA analog induced a long-lasting facilitation of hippocampal
neurotransmission, as assessed by the persistent enhancement
in the activity of presynaptic nAChRs via a PKC pathway
(Tanaka and Nishizaki, 2003; Yamamoto et al., 2005). 4-[4-
(Z)-hept-1-enyl-phenoxy] butyric acid (HUHS2002) potentiated
rat α7 nAChR currents, an effect that was not affected by the
addition of an inhibitor of PKC but significantly inhibited by
an inhibitor of CaMKII (Kanno et al., 2012a). This suggests
that HUHS2002 potentiates α7 nAChR currents by activation of
CaMKII. However, HUHS2002might indirectly activate CaMKII
by inhibiting protein phosphatase 1 (PP1), which normally
dephosphorylates and inactivates CaMKII. Another linoleic acid
derivative with cyclopropane rings instead of cis-double bonds
(DCP-LA) preserved the potentiation effect on nAChR currents,
which was abolished by GF109203X, a PKC inhibitor (Kanno
et al., 2012b). The DCP-LA effect (a) was significantly inhibited
by vesicular transport inhibitors, (b) promoted the translocation
of the α7 nAChR from the cytosol to the plasma membrane and
(c) stimulated α7 nAChR delivery toward presynaptic terminals.
The evidence suggests that the nAChR current potentiation could
arise from the DCP-LAmediated stimulation of nAChR vesicular
transport and the consequent increase in the number of nAChR
targeted to the cell surface (Kanno et al., 2012b). This was the first
postulation of PKC control of intracellular α7 nAChR trafficking;
which PKC targets participate in this regulation is still not
known. Subsequent studies showed that DCP-LA significantly
increased an association of 4.1N -a scaffolding protein- with
α7 nAChR; and that this association is partially prevented by
GF109203X, an inhibitor of PKC, but independently of 4.1N
phosphorylation (Kanno et al., 2013). The same study showed
for the first time that 4.1N is required for translocation of
the α7 nAChR toward the plasma membrane. Thus, DCP-
LA could induce an increase in the association of the α7
nAChR with 4.1N in a PKC-dependent manner, not caused
by PKC phosphorylation of 4.1N or by phosphorylation of the
receptor. Probably DCP-LA, by activating PKC, phosphorylates
an unknown factor that enhances the association of 4.1N with
the α7 nAChR (Kanno et al., 2013). Thus, the evidence described
in the last paragraphs point to a novel pathway linking lipid
signaling to α7 nAChR responses, as is graphically summarized
in Figure 3.
FIGURE 3 | Schematic diagram of indirect mechanisms of action of FFA on neuronal nAChR function. Different FFA, or their derivatives, can modulate α7
nAChR through various signaling pathways. See text for details.
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One avenue that needs to be explored in greater detail is the
involvement of abnormalities of FAmetabolism in brain diseases.
Circulating long-chain fatty acids act as signals of nutrient
surplus in the hypothalamus. Furthermore, pharmacological
and/or genetic inhibition of FA synthase, AMP-activated protein
kinase and carnitine palmitoyl transferase 1 (CPT1) results in
marked decreases in feeding levels and loss of body weight in
rodents (López et al., 2007). CPT1c, the recently discovered brain
isoform of the multiprotein complex enzyme carnitine palmitoyl
transferase, is predominantly localized in regions involved in
the regulation of food intake, such as the hypothalamus,
emotion and reward systems -the amygdala- and learning and
memory, the hippocampus. CPT activity has been associated
with dysregulation of insulin equilibrium in brain and related
metabolic dysfunctions, and implicated in the evolution of
Parkinson’s and Alzheimer’s diseases (Virmani et al., 2015).
CONCLUSIONS
When analyzing the effects of FFA on a variety of ion channels,
one of the first clear outcomes is that different FFA exert distinct
effects, or no effect at all, on a same channel protein, whereas
similar FFA may cause diverse effects on different proteins,
even if the latter are very closely related from a phylogenetic
point of view. In spite of these apparent discrepancies, it is
clear that almost all FFA that modulate the ion channel directly,
i.e., not through their metabolites or signaling cascades, act
by direct physical contact with the protein. Direct mechanisms
consequently put both FFA structure and channel structure -
particularly those amino acids that participate in the interaction-
at center stage. Amino acid residues involved in the recognition
of FFA are apparently sensitive to the length, isomerism and
saturation of the FFA. It is thus mandatory to identify and
characterize in detail the structure of the intervening binding
site(s) in the protein and the counteracting FFA structure to
unravel the different inhibitory or stimulatory modalities at the
molecular level and eventually contribute to the design of new
lipid-based modulatory drugs targeting specific channel proteins.
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